Novel Foods

 

Safety assessment of novel foods and GLP-compliant toxicological studies

Novel food products may be placed on the market in the European Union (EU) in accordance with Regulation (EU) 2015/2283, provided it has been scientifically demonstrated that they are safe for human consumption. The toxicological safety assessment includes GLP-compliant toxicological studies, repeated-dose oral toxicity studies (typically 90 days), a genotoxicity battery, an allergenicity assessment, and, where applicable, ADME studies (absorption, distribution, metabolism, excretion) and additional toxicological studies, as well as a nutritional evaluation. This article summarizes the toxicological aspect of the safety assessment of "novel food" and the role of GLP-compliant studies.

"Novel food" encompasses categories such as foods that were not consumed to a significant degree in the EU before 1997, foods obtained by new production processes, foods based on microorganisms, cultures, or fungi, as well as algae, insects, and nanomaterials. The safety assessment is conducted in accordance with EFSA guidelines on "novel food" and the corresponding legal framework. The toxicological evaluation is designed taking into account the product description, the manufacturing process, the composition, the recommended intake, and the target group. A GLP-compliant (Good Laboratory Practice) study ensures that the organization of the test facility, quality assurance, SOPs, raw data collection, reporting, and archiving comply with OECD GLP principles, and guarantees the reliability and traceability of the data.

1. Toxicological studies

Toxicological studies are conducted to demonstrate the safe consumption of the novel food. The studies require compliance with predefined SOPs regarding the characterization of the test substance, dose selection, control groups, observation parameters, histopathological evaluation, and statistical analyses. The toxicological program is planned in a tiered manner according to the risk profile of the product and the recommended usage amount. Compliance with GLP guidelines alone does not imply scientific validity; it must be evaluated in conjunction with compliance with OECD test guidelines and method validation.

2. Repeated-dose oral toxicity studies

To evaluate the effects of long-term consumption, 90-day in vivo studies (OECD TG 408) are typically performed. In these studies:

target organ toxicity is determined.

  • Systemic effects are evaluated.
  • Safe intake levels (NOAEL/LOAEL) are determined.

3. Genotoxicity assessment

To rule out the potential for damage to genetic material, a standardized genotoxicity test battery is applied:

In vitro tests: OECD TG 471 (bacterial reverse mutation / Ames test), OECD TG 487 (in vitro micronucleus test), OECD TG 476 or 490 (gene mutation in mammalian cells).

  • In vivo genotoxicity studies: OECD TG 474 (bone marrow micronucleus test) or OECD TG 489 (comet assay).

4. Allergenicity assessment

The potential for allergic reactions is a critical safety parameter for novel foods. The assessment employs the following methods:

  • Structural analyses (sequence homology with known allergens, IgE epitope similarity),
  • Digestibility studies (stability in simulated gastrointestinal fluids),
  • supporting toxicological data.

5. ADME and additional toxicological studies

If necessary, to investigate the behavior of the product in the body:

Absorption, distribution, metabolism, and excretion (ADME) studies (OECD TG 417, toxicokinetics) can be performed.

  • In addition, depending on the risk profile, reproductive and developmental toxicity studies (OECD TG 421/422, 414, 416) may be required.

6. Nutritional evaluation

In addition to the toxicological assessment, the novel food must also be evaluated from a nutritional perspective. The nutritional evaluation includes compositional analysis, nutrient content, bioavailability, anti-nutritional factors, as well as the effects on nutrient intake at the recommended intake level. The nutritional evaluation is assessed together with the toxicological data, thus contributing to the establishment of the safe intake level and labeling requirements.

For all details and inquiries, please feel free to contact us.